Tariquidar 126(ZZ) Atracurium is classified as an

Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent

indicating that the drug directly interacts with tubulin at the colchicine-binding site

in ACS Med Chem Lett

PubMed Central PMCID: PMC6004690

2-oxazol-3-yl]urea

Tariquidar 126(ZZ) Atracurium is classified as anTariquidar, also known as XR9576, is a P glycoprotein (P gp) inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. Tariquidar non competitively binds to the p glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs. Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity. Product information CAS